(Press-News.org) It sounds like science fiction but a team from the University of Exeter, with support from Shell, has developed a method to make bacteria produce diesel on demand. While the technology still faces many significant commercialisation challenges, the diesel, produced by special strains of E. coli bacteria, is almost identical to conventional diesel fuel and so does not need to be blended with petroleum products as is often required by biodiesels derived from plant oils. This also means that the diesel can be used with current supplies in existing infrastructure because engines, pipelines and tankers do not need to be modified. Biofuels with these characteristics are being termed 'drop-ins'.
Professor John Love from Biosciences at the University of Exeter said: "Producing a commercial biofuel that can be used without needing to modify vehicles has been the goal of this project from the outset. Replacing conventional diesel with a carbon neutral biofuel in commercial volumes would be a tremendous step towards meeting our target of an 80% reduction in greenhouse gas emissions by 2050. Global demand for energy is rising and a fuel that is independent of both global oil price fluctuations and political instability is an increasingly attractive prospect."
E. coli bacteria naturally turn sugars into fat to build their cell membranes. Synthetic fuel oil molecules can be created by harnessing this natural oil production process. Large scale manufacturing using E. coli as the catalyst is already commonplace in the pharmaceutical industry and, although the biodiesel is currently produced in tiny quantities in the laboratory, work will continue to see if this may be a viable commercial pathway to 'drop in' fuels.
Rob Lee from Shell Projects & Technology said: "We are proud of the work being done by Exeter in using advanced biotechnologies to create the specific hydrocarbon molecules that we know will continue to be in high demand in the future. While the technology still faces several hurdles to commercialisation, by exploring this new method of creating biofuel, along with other intelligent technologies, we hope they could help us to meet the challenges of limiting the rise in carbon dioxide emissions while responding to the growing global requirement for transport fuel."
INFORMATION:
This work was supported by a grant from Shell Research Ltd and a Biotechnology and Biological Sciences Research Council (BBSRC) Industry Interchange Partnership Grant.
About the University of Exeter
The Sunday Times University of the Year 2012-13, the University of Exeter is a Russell Group university and in the top one percent of institutions globally. It combines world-class research with very high levels of student satisfaction. Exeter has over 18,000 students and is ranked 7th in The Sunday Times University Guide, 10th in the UK in The Times Good University Guide 2012 and 10th in the Guardian University Guide. In the 2008 Research Assessment Exercise (RAE) 90% of the University's research was rated as being at internationally recognised levels and 16 of its 31 subjects are ranked in the top 10, with 27 subjects ranked in the top 20.
The University has invested strategically to deliver more than £350 million worth of new facilities across its campuses for 2012, including landmark new student services centres - the Forum in Exeter and The Exchange in Cornwall - and world-class new facilities for Biosciences, the Business School and the Environment and Sustainability Institute.
http://www.exeter.ac.uk
For further information:
Dr Jo Bowler
University of Exeter Press Office
Office: +44 (0)1392 722062
Mobile: +44(0)7827 309 332
j.bowler@exeter.ac.uk
Bugs produce diesel on demand
2013-04-23
ELSE PRESS RELEASES FROM THIS DATE:
Radioactive bacteria targets metastatic pancreatic cancer
2013-04-23
VIDEO:
Claudia Gravekamp, Ph.D., discusses her research on a new therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. Dr. Gravekamp is...
Click here for more information.
April 22, 2013 — (BRONX, NY) — Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes ...
Hepatitis c-like viruses identified in bats and rodents
2013-04-23
As many as one in 50 people around the world is infected with some type of hepacivirus or pegivirus, including up to 200 million with hepatitis C virus (HCV), a leading cause of liver failure and liver cancer. There has been speculation that these agents arose in wildlife and jumped species to infect humans; however, little was known about their distribution in other species.
In two new papers published in the journals mBio and Proceedings of the National Academy of Sciences, investigators at the Center for Infection and Immunity (CII) at Columbia University's Mailman ...
New light shed on early stage Alzheimer's disease
2013-04-23
The disrupted metabolism of sugar, fat and calcium is part of the process that causes the death of neurons in Alzheimer's disease. Researchers from Karolinska Institutet in Sweden have now shown, for the first time, how important parts of the nerve cell that are involved in the cell's energy metabolism operate in the early stages of the disease. These somewhat surprising results shed new light on how neuronal metabolism relates to the development of the disease.
In the Alzheimer's disease brain, plaques consisting of so called amyloid-beta-peptide (Aβ) are accumulated. ...
Stanford researchers develop new method to assess options for heart-disease surgery
2013-04-23
STANFORD, Calif. — Researchers at the Stanford University School of Medicine have developed a method of predicting which patients with heart disease would benefit more from surgery and which would benefit more from angioplasty.
Drawing on Medicare records of more than 100,000 patients with heart disease, the team demonstrated that the effectiveness of coronary bypass surgery varied widely based on each individual's characteristics. The data enabled them to predict which type of intervention — coronary bypass surgery or coronary angioplasty — increased the chances of an ...
Scientists find antibody that transforms bone marrow stem cells directly into brain cells
2013-04-23
LA JOLLA, CA – April 22, 2013 – In a serendipitous discovery, scientists at The Scripps Research Institute (TSRI) have found a way to turn bone marrow stem cells directly into brain cells.
Current techniques for turning patients' marrow cells into cells of some other desired type are relatively cumbersome, risky and effectively confined to the lab dish. The new finding points to the possibility of simpler and safer techniques. Cell therapies derived from patients' own cells are widely expected to be useful in treating spinal cord injuries, strokes and other conditions ...
Geochemical method finds links between terrestrial climate and atmospheric carbon dioxide
2013-04-23
Nearly thirty-four million years ago, the Earth underwent a transformation from a warm and high-carbon dioxide "greenhouse" state to a lower-CO2, variable climate of the modern "icehouse" world. Massive ice sheets grew across the Antarctic continent, major animal groups shifted, and ocean temperatures decreased by up to 5 degrees.
But studies of how this drastic change affected temperatures on land have had mixed results. Some show no appreciable terrestrial climate change; others find cooling of up to 8 degrees and large changes in seasonality.
Now, a group of American ...
Biological activity alters the ability of sea spray to seed clouds
2013-04-23
Ocean biology alters the chemical composition of sea spray in ways that influence their ability to form clouds over the ocean. That's the conclusion of a team of scientists using a new approach to study tiny atmospheric particles called aerosols that can influence climate by absorbing or reflecting sunlight and seeding clouds.
"After many decades of attempting to understand how the ocean impacts the atmosphere and clouds above it, it became clear a new approach was needed to investigate the complex ocean-atmosphere system—so moving the chemical complexity of the ocean ...
Highly active antiretroviral therapies may be cardioprotective in HIV-infected children, teens
2013-04-23
Long-term use of highly active antiretroviral therapies (HAART) does not appear to be associated with impaired heart function in children and adolescents in a study that sought to determine the cardiac effects of prolonged exposure to HAART on children infected with the human immunodeficiency virus (HIV), according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Prior to contemporary antiretroviral therapies (ARTs), children infected with HIV were more likely to have heart failure.
Steven E. Lipshultz, M.D., of the University of Miami ...
Study evaluates Mobile Acute Care of the Elderly (MACE) service vs. usual elder care
2013-04-23
A matched cohort study by William W. Hung, M.D., M.P.H., of the Mount Sinai School of Medicine, New York, and colleagues examined the use of the Mobile Acute Care of the Elderly (MACE) service compared with general medical service (usual care). (Online First)
Patients were recruited for the study if they were 75 years or older and were admitted because of an acute illness to either the MACE service, a novel model of care delivered by an interdisciplinary team and designed to deliver specialized care to hospitalized older adults to improve patient outcomes, or usual care. ...
Diagnostic errors more common, costly and harmful than treatment mistakes
2013-04-23
In reviewing 25 years of U.S. malpractice claim payouts, Johns Hopkins researchers found that diagnostic errors — not surgical mistakes or medication overdoses — accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts. Diagnosis-related payments amounted to $38.8 billion between 1986 and 2010, they found.
"This is more evidence that diagnostic errors could easily be the biggest patient safety and medical malpractice problem in the United States," says David E. Newman-Toker, M.D., Ph.D., an associate professor ...